Coadministration with CYP3A4 substrates, particularly Those people that has a narrow therapeutic index, may lead to lowered concentrations and loss of efficacy. If not able to steer clear of coadministration, keep an eye on CYP3A4 substrate ranges and regulate dose as wanted.bremelanotide will lower the extent or effect of triazolam by Other (see r